Heikki Tuominen1, Atte Haarala2, Antti Tikkakoski2, Pasi Korkola2, Mika Kähönen3, Kjell Nikus3,4, Kalle Sipilä2. 1. Department of Clinical Physiology and Nuclear Medicine, Tampere University Hospital, 33520, Tampere, Finland. heikki.tuominen@pshp.fi. 2. Department of Clinical Physiology and Nuclear Medicine, Tampere University Hospital, 33520, Tampere, Finland. 3. Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. 4. Heart Center, Tampere University Hospital, Tampere, Finland.
Abstract
INTRODUCTION: Fluorodeoxyglucose positron emission tomography (FDG-PET) is a non-invasive imaging modality that has been shown to be a feasible method to demonstrate myocardial inflammation. The aim of this study was to identify the patients suspected of having cardiac sarcoidosis (CS), who are most likely to benefit from PET imaging. MATERIALS AND METHODS: 137 patients suspected of having CS underwent a dedicated cardiac FDG-PET examination at Tampere University Hospital between August 2012 and September 2015. These examinations were retrospectively analyzed. RESULTS: 33 and 12 of the 137 patients had abnormal left and right ventricular (LV and RV) FDG-uptake, respectively. Abnormal LV-uptake and RV-uptake were significantly associated with female sex and a history of advanced AV-block (P < 0.05). Abnormal RV-uptake was also associated with ventricular tachycardia and atrial fibrillation (P < 0.05). 56% of the 27 female patients with a history of AV-block had a pathological PET finding compared to only 6% of the 49 male patients without a history of AV-block. There were 17 female patients with history of both AV-block and ventricular tachycardia, 71% of them had abnormal PET finding. CONCLUSIONS: Abnormal FDG-PET findings were associated with female sex, AV-block, and arrhythmias in this clinical cohort.
INTRODUCTION:Fluorodeoxyglucose positron emission tomography (FDG-PET) is a non-invasive imaging modality that has been shown to be a feasible method to demonstrate myocardial inflammation. The aim of this study was to identify the patients suspected of having cardiac sarcoidosis (CS), who are most likely to benefit from PET imaging. MATERIALS AND METHODS: 137 patients suspected of having CS underwent a dedicated cardiac FDG-PET examination at Tampere University Hospital between August 2012 and September 2015. These examinations were retrospectively analyzed. RESULTS: 33 and 12 of the 137 patients had abnormal left and right ventricular (LV and RV) FDG-uptake, respectively. Abnormal LV-uptake and RV-uptake were significantly associated with female sex and a history of advanced AV-block (P < 0.05). Abnormal RV-uptake was also associated with ventricular tachycardia and atrial fibrillation (P < 0.05). 56% of the 27 female patients with a history of AV-block had a pathological PET finding compared to only 6% of the 49 male patients without a history of AV-block. There were 17 female patients with history of both AV-block and ventricular tachycardia, 71% of them had abnormal PET finding. CONCLUSIONS: Abnormal FDG-PET findings were associated with female sex, AV-block, and arrhythmias in this clinical cohort.
Authors: David H Birnie; William H Sauer; Frank Bogun; Joshua M Cooper; Daniel A Culver; Claire S Duvernoy; Marc A Judson; Jordana Kron; Davendra Mehta; Jens Cosedis Nielsen; Amit R Patel; Tohru Ohe; Pekka Raatikainen; Kyoko Soejima Journal: Heart Rhythm Date: 2014-05-09 Impact factor: 6.343
Authors: Rajat Kalra; Shray Malik; Ko-Hsuan Amy Chen; Fredrick Ogugua; Pal Satyajit Singh Athwal; Andrew C Elton; Pratik S Velangi; Mohamed F Ismail; Sanya Chhikara; Jeremy S Markowitz; Prabhjot S Nijjar; Lisa von Wald; Henri Roukoz; Maneesh Bhargava; David Perlman; Chetan Shenoy Journal: Circ Arrhythm Electrophysiol Date: 2021-09-01
Authors: Riemer H J A Slart; Andor W J M Glaudemans; Olivier Gheysens; Mark Lubberink; Tanja Kero; Marc R Dweck; Gilbert Habib; Oliver Gaemperli; Antti Saraste; Alessia Gimelli; Panagiotis Georgoulias; Hein J Verberne; Jan Bucerius; Christoph Rischpler; Fabien Hyafil; Paola A Erba Journal: Eur Heart J Cardiovasc Imaging Date: 2020-12-01 Impact factor: 6.875
Authors: Riemer H J A Slart; Andor W J M Glaudemans; Olivier Gheysens; Mark Lubberink; Tanja Kero; Marc R Dweck; Gilbert Habib; Oliver Gaemperli; Antti Saraste; Alessia Gimelli; Panagiotis Georgoulias; Hein J Verberne; Jan Bucerius; Christoph Rischpler; Fabien Hyafil; Paola A Erba Journal: Eur J Nucl Med Mol Imaging Date: 2020-10-27 Impact factor: 9.236